PNNL Publishes Microreactor Incident-Free Transportation Radiation Dose Assessment for NRC

Pacific Northwest National Laboratory published a technical report on February 21, 2026 titled Microreactor Incident‑Free Transportation Radiation Dose Assessment, prepared for the U.S. Nuclear Regulatory Commission. The report provides incident-free transportation radiation dose estimates for microreactors, giving the NRC quantified results to consider as microreactor projects move toward deployment.

The analysis released by PNNL on February 21, 2026 is framed as a technical assessment aimed at routine transport conditions for microreactor hardware and materials. Pacific Northwest National Laboratory’s work and the report title signal a focus on “incident-free” scenarios rather than accident source terms, and the document was produced specifically for the U.S. Nuclear Regulatory Commission’s use in regulatory and review activities.

For stakeholders tracking microreactor logistics, the February 21, 2026 report adds measurable outputs to the record. Pacific Northwest National Laboratory’s assessment supplies the Nuclear Regulatory Commission with modeled dose estimates tied to transport operations, which will be part of the material NRC staff can reference when evaluating transport safety analyses, licensing submissions, or consultation requests from vendors and utilities.

Operators and developers engaged in microreactor programs should note the publication date: February 21, 2026. PNNL’s report title, Microreactor Incident‑Free Transportation Radiation Dose Assessment, makes clear the scope and intention of the work submitted to the U.S. Nuclear Regulatory Commission and sets a technical baseline that project teams can compare to their own transport packaging and routing plans.

As of February 25, 2026 the Nuclear Reactions community now has a fresh, PNNL‑authored technical assessment to examine. Pacific Northwest National Laboratory’s deliverable to the U.S. Nuclear Regulatory Commission represents a concrete data point in the ongoing process of integrating microreactor systems into existing transport and regulatory frameworks, and it will be important for developers, carriers, and regulators to align their next steps with the dose estimates and assumptions laid out in the February 21, 2026 report.